Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 56 | 59 | +3 |
| Shares | 2.88M | 4.49M | +1.61M (+56.1%) |
| Value | $21.2M | $47.8M | +$26.6M (+125.4%) |
New holders (11)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 197,021 | $2.10M | 0.43% |
| EAM Global Investors LLC | 115,387 | $1.23M | 0.32% |
| ExodusPoint Capital Management, LP | 46,347 | $494.0K | 0.01% |
| Endurant Capital Management LP | 45,612 | $485.8K | 0.20% |
| Cubist Systematic Strategies, LLC | 34,298 | $365.3K | 0.00% |
| Marshall Wace, LLP | 22,459 | $239.2K | 0.00% |
| Jane Street Group, LLC | 19,462 | $207.3K | 0.00% |
| 683 Capital Management, LLC | 16,629 | $177.1K | 0.02% |
| Man Group plc | 12,901 | $137.4K | 0.00% |
| Advisory Services Network, LLC | 1,000 | $10.7K | 0.00% |
| Freedom Wealth Alliance, LLC | 703 | $7.49K | 0.01% |
Sold out (8)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Franklin Resources Inc | 20,709 | $153.0K |
| Delphia (USA) Inc. | 14,226 | $105.0K |
| Corton Capital Inc. | 13,966 | $103.0K |
| Leonteq Securities AG | 12,000 | $89.3K |
| Emfo, LLC | 1,666 | $12.0K |
| Global Financial Private Client, LLC | 266 | $1.97K |
| Retirement Group, LLC | 79 | $1.00K |
| Axiom Investment Management LLC | 5 | $0 |